NoMA

• 

  Updated Guidelines on Pharmaceutical Marketing – What Does It Mean for You?

  On December 19, 2024, the Norwegian Medical Products Agency (NOMA) published updated guidelines on pharmaceutical marketing regulations. These updates are intended for the pharmaceutical industry, pharmacies, clinics, and other entities involved in marketing medicinal products for humans and animals. The revised guidelines introduce important changes, both linguistic and structural. Why Is This Important? Pharmaceutical marketing […]

• 

  Use digital package leaflets!

  The Norwegian Medical Products Agency (NOMA) recommends the use of digital package leaflets. All medicinal products have package leaflets with important information about correct use. In Norway, these leaflets are also available digitally on the website of The Norwegian Pharmaceutical Product Compendium

• 

  High quality Norwegian product information

  The Norwegian Medicines Agency (NoMA) strongly encourages marketing authorisation holders (MAH) to focus on high quality translations of product information (PI): “The product information has to be easy to read and understand for the users. A higher quality of the product information will improve the patient information and contribute to safe use of medicines. There […]